DNAJB4 and breast carcinoma: Chen et al. used Lats-IN-1 to inhibit Hippo pathway and found that overexpression of DNAJB4 suppressed the adverse biological characteristics of breast cancer through modulation of the Hippo pathway and the tumor’s immune suppression context.